Gemma Alderton

1.5k total citations
227 papers, 1.2k citations indexed

About

Gemma Alderton is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gemma Alderton has authored 227 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 49 papers in Oncology and 46 papers in Cancer Research. Recurrent topics in Gemma Alderton's work include Cancer Genomics and Diagnostics (21 papers), Epigenetics and DNA Methylation (16 papers) and Cancer Cells and Metastasis (13 papers). Gemma Alderton is often cited by papers focused on Cancer Genomics and Diagnostics (21 papers), Epigenetics and DNA Methylation (16 papers) and Cancer Cells and Metastasis (13 papers). Gemma Alderton collaborates with scholars based in United Kingdom and Germany. Gemma Alderton's co-authors include Mark O’Driscoll, Penny A. Jeggo, Lisa Woodbine, Tom Stiff, Raymonda Varon, Anders D. Børglum, Hans Joenje, Yvonne Bordon, Heidemarie Neitzel and Kathy H. Surinya and has published in prestigious journals such as Science, Nature Reviews Molecular Cell Biology and Nature reviews. Cancer.

In The Last Decade

Gemma Alderton

206 papers receiving 1.2k citations

Peers

Gemma Alderton

MB

CR

ONCOL

CB

GENET

Hanshuo Yang China

Alihossein Saberi Iran

Saiful Effendi Syafruddin Malaysia

Jingyi Yu China

Francis Jacob Switzerland

Dora Cavallo‐Medved Canada

Hirokazu Ohata Japan

Rachel J. Buchsbaum United States

Andrea Kinner Germany

Fabio Cerignoli United States

Hanshuo Yang China

Gemma Alderton

656 ×0.8

MB

228 ×0.7

CR

261 ×0.8

ONCOL

195 ×1.1

CB

90 ×0.8

GENET

Citations per year, relative to Gemma Alderton Gemma Alderton (= 1×) peers Hanshuo Yang

Countries citing papers authored by Gemma Alderton

Since Specialization

Citations

This map shows the geographic impact of Gemma Alderton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Alderton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Alderton more than expected).

Fields of papers citing papers by Gemma Alderton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Alderton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Alderton. The network helps show where Gemma Alderton may publish in the future.

Co-authorship network of co-authors of Gemma Alderton

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Alderton. A scholar is included among the top collaborators of Gemma Alderton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Alderton. Gemma Alderton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Alderton, Gemma & Seth Thomas Scanlon. (2023). When a delicate balancing act goes wrong. Science. 380(6644). 468–469. 1 indexed citations

2.

Alderton, Gemma & Seth Thomas Scanlon. (2021). Inflammation. Science. 374(6571). 1068–1069. 13 indexed citations

3.

Lavine, Marc S., Claire Olingy, Beverly A. Purnell, et al.. (2020). This Week in Science. Science. 370(6519). 926–928. 1 indexed citations

4.

Alderton, Gemma. (2020). Metabolism as cancer progresses. Science. 368(6487). 149.10–151. 1 indexed citations

5.

Szuromi, Phil, Keith T. Smith, Ian S. Osborne, et al.. (2019). This Week in Science. Science. 366(6466). 702–704.

6.

Smith, Keith T., Wei Wong, Jelena Stajic, et al.. (2018). This Week in Science. Science. 362(6418). 1014–1016. 3 indexed citations

7.

Lavine, Marc S., Pamela J. Hines, Julia Fahrenkamp-Uppenbrink, et al.. (2018). This Week in Science. Science. 359(6382). 1373–1375. 2 indexed citations

8.

Alderton, Gemma. (2015). Searching for early events. Nature reviews. Cancer. 16(1). 5–5.

9.

Alderton, Gemma. (2015). Intestinal bacteria are in command. Nature reviews. Immunology. 16(1). 5–5. 8 indexed citations

10.

Alderton, Gemma. (2015). Splicing up your survival. Nature reviews. Cancer. 15(10). 575–575. 2 indexed citations

11.

Alderton, Gemma. (2014). Using CTCs to test drug sensitivity. Nature Reviews Drug Discovery. 13(9). 654–654. 3 indexed citations

12.

Alderton, Gemma. (2014). Turning macrophages on, off and on again. Nature reviews. Immunology. 14(3). 137–137. 11 indexed citations

13.

Alderton, Gemma. (2014). Two hits are better than one. Nature reviews. Immunology. 14(7). 431–431. 1 indexed citations

14.

Alderton, Gemma. (2013). To me, to you. Nature reviews. Cancer. 13(11). 756–757. 5 indexed citations

15.

Alderton, Gemma. (2013). DNA transitions. Nature reviews. Cancer. 13(4). 221–221. 2 indexed citations

16.

Alderton, Gemma. (2012). Reprogramming ERα. Nature reviews. Cancer. 12(2). 79–79. 2 indexed citations

17.

Alderton, Gemma. (2007). Tolerance is not a virtue. Nature reviews. Cancer. 7(4). 231–231. 1 indexed citations

18.

Alderton, Gemma, Elen Griffith, Kathy H. Surinya, et al.. (2006). Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nature Cell Biology. 8(7). 725–733. 134 indexed citations

19.

Alderton, Gemma, Hans Joenje, Raymonda Varon, et al.. (2004). Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Human Molecular Genetics. 13(24). 3127–3138. 140 indexed citations

20.

Stiff, Tom, et al.. (2004). Nbs1 is required for ATR‐dependent phosphorylation events. The EMBO Journal. 24(1). 199–208. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact